Matthew Speers
Vorstandsvorsitzender bei IC-VEC Ltd.
Profil
Matthew Speers has been Chief Executive Officer of IC-VEC Ltd.
since 2004.
Prior to joining IC-Vec, he was a Vice President of Plexus Ventures.
Previously, he worked for GlaxoSmithKline.
Mr. Speers has 20 years of experience in the pharmaceutical industry.
Aktive Positionen von Matthew Speers
| Unternehmen | Position | Beginn |
|---|---|---|
IC-VEC Ltd.
 IC-VEC Ltd. Miscellaneous Commercial ServicesCommercial Services IC-VEC Ltd. is a biotechnology firm and do research and development for non-viral drug delivery systems. The company's therapeutic areas are cancer and liver diseases. IC-VEC plans to use its technology to develop DNA based and cancer vaccines. The company was founded in December 2001 by Andrew Miller and is headquartered in London, UK | Vorstandsvorsitzender | 01.04.2004 |
Ehemalige bekannte Positionen von Matthew Speers
| Unternehmen | Position | Ende |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
IC-VEC Ltd.
IC-VEC Ltd. Miscellaneous Commercial ServicesCommercial Services IC-VEC Ltd. is a biotechnology firm and do research and development for non-viral drug delivery systems. The company's therapeutic areas are cancer and liver diseases. IC-VEC plans to use its technology to develop DNA based and cancer vaccines. The company was founded in December 2001 by Andrew Miller and is headquartered in London, UK | Commercial Services |
